Vagal activity enhances macrophage phagocytosis surveillance <strong>of</strong> luminal antigen uptake by inducing a transient incre<strong>as</strong>e in epithelial permeability and augmenting the uptake <strong>of</strong> luminal bacteria by mucosal macrophages. Our data confirm the intimate involvement <strong>of</strong> the autonomous nervous system in the maintenance <strong>of</strong> mucosal barrier function 23,31,32 . Our current finding <strong>of</strong> the <strong>vagus</strong> <strong>nerve</strong> regulating the mucosal barrier function is in agreement with earlier reports <strong>of</strong> cholinergic regulation <strong>of</strong> enterocyte endocytosis and <strong>intestinal</strong> epithelial permeability 20 , although epithelial signaling is thought to be mediated via nonneuronal ACh production 21 . <strong>The</strong> cholinergic modulation <strong>of</strong> the epithelial barrier function w<strong>as</strong> not explained by altered tight junction protein expression, <strong>as</strong> levels <strong>of</strong> occludin and claudin-2 were not affected in <strong>intestinal</strong> tissue from mice that underwent <strong>vagus</strong> <strong>nerve</strong> stimulation (results not shown). A possible alternative explanation for the transient reduction <strong>of</strong> barrier function after VNS is that stimulation <strong>of</strong> vagal activity, under normal physiological conditions, leads to a reduction in mean arterial blood pressure, a parameter that is shown to mediate tight junction integrity 33 . Hence, although vagal activation preserves barrier function under pathological conditions such <strong>as</strong> ischemia, via its anti-inflammatory actions, our data indicate that enhanced <strong>vagus</strong> <strong>nerve</strong> activity under physiological conditions can allow transient p<strong>as</strong>sage <strong>of</strong> antigens, possibly to <strong>as</strong>sist in routine surveillance. <strong>The</strong> physiological relevance <strong>of</strong> this system is currently under investigation. 95
Chapter 5 REFERENCE LIST 96 1. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus <strong>nerve</strong> stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-462. 2. Tracey KJ. <strong>The</strong> inflammatory reflex. Nature 2002;420:853-859. 3. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L. Cholinergic agonists inhibit HMGB1 rele<strong>as</strong>e and improve survival in experimental sepsis. Nat Med 2004;10:1216-1221. 4. <strong>The</strong> FO, Boeckxstaens GE, Snoek SA, C<strong>as</strong>h JL, Bennink R, Larosa GJ, van den Wijngaard RM, Greaves DR, De Jonge WJ. Activation <strong>of</strong> the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. G<strong>as</strong>troenterology 2007;133:1219-1228. 5. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al Abed Y, Czura CJ, Tracey KJ. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator <strong>of</strong> <strong>inflammation</strong>. Nature 2003;421:384-388. 6. De Jonge WJ, van der Zanden EP, <strong>The</strong> FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM, Boeckxstaens GE. Stimulation <strong>of</strong> the <strong>vagus</strong> <strong>nerve</strong> attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005;6:844-851. 7. Ghia JE, Blennerh<strong>as</strong>sett P, Kumar-Ondiveeran H, Verdu EF, Collins SM. <strong>The</strong> <strong>vagus</strong> <strong>nerve</strong>: a tonic inhibitory influence <strong>as</strong>sociated with inflammatory bowel dise<strong>as</strong>e in a murine model. G<strong>as</strong>troenterology 2006;131:1122-1130. 8. van Westerloo DJ, Giebelen IA, Florquin S, Daalhuisen J, Bruno MJ, de Vos AF, Tracey KJ, van der PT. <strong>The</strong> cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 2005;191:2138-2148. 9. Giebelen IA, van Westerloo DJ, Larosa GJ, de Vos AF, van der PT. Stimulation <strong>of</strong> alpha 7 cholinergic receptors inhibits lipopolysaccharide-induced neutrophil recruitment by a tumor necrosis factor alpha-independent mechanism. Shock 2007;27:443-447. 10. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH, Buurman WA. Nutritional stimulation <strong>of</strong> cholecystokinin receptors inhibits <strong>inflammation</strong> via the <strong>vagus</strong> <strong>nerve</strong>. J Exp Med 2005;202:1023-1029. 11. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, Orenstein JM, Smith PD. Human <strong>intestinal</strong> macrophages display pr<strong>of</strong>ound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005;115:66-75. 12. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vy<strong>as</strong> JM, Boes M, Ploegh HL, Fox JG, Littman DR, Reinecker HC. CX3CR1-mediated dendritic cell access to the <strong>intestinal</strong> lumen and bacterial clearance. Science 2005;307:254-258. 13. Kessler W, Traeger T, Westerholt A, Neher F, Mikulcak M, Muller A, Maier S, Heidecke CD. <strong>The</strong> vagal <strong>nerve</strong> <strong>as</strong> a link between the nervous and immune system in the instance <strong>of</strong> polymicrobial sepsis. Langenbecks Arch Surg 2006;391:83-87. 14. Giebelen IA, Le Moine A, van den Pangaart PS, Sadis C, Goldman M, Florquin S, van der PT. Deficiency <strong>of</strong> alpha7 cholinergic receptors facilitates bacterial clearance in Escherichia coli peritonitis. J Infect Dis 2008;198:750-757. 15. Desmedt M, Rottiers P, Dooms H, Fiers W, Grooten J. Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses. J Immunol 1998;160:5300-5308. 16. Smith PD, Smythies LE, Mosteller-Barnum M, Sibley DA, Russell MW, Merger M, Sellers MT, Orenstein JM, Shimada T, Graham MF, Kubagawa H. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 2001;167:2651-2656. 17. Papke RL, Buhr JD, Francis MM, Choi KI, Thinschmidt JS, Horenstein NA. <strong>The</strong> effects <strong>of</strong> subunit composition on the inhibition <strong>of</strong> nicotinic receptors by the amphipathic blocker 2,2,6,6-tetramethylpiperidin-4-yl heptanoate. Mol <strong>Pharma</strong>col 2005;67:1977-1990.